|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dekker E, Tanis PJ, Vleugels JL, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fujita T: Colorectal cancer. Lancet.
376:331–332. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stein A, Atanackovic D and Bokemeyer C:
Current standards and new trends in the primary treatment of
colorectal cancer. Eur J Cancer. 47 (Suppl 3):S312–S314. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fakih MG: Metastatic colorectal cancer:
Current state and future directions. J Clin Oncol. 33:1809–1824.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boland PM and Ma WW: Immunotherapy for
colorectal cancer. Cancers (Basel). 9:502017. View Article : Google Scholar
|
|
7
|
Syn NL, Teng MWL, Mok TSK and Soo RA:
De-novo and acquired resistance to immune checkpoint targeting.
Lancet Oncol. 18:e731–e741. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brenner H and Chen C: The colorectal
cancer epidemic: Challenges and opportunities for primary,
secondary and tertiary prevention. Br J Cancer. 119:785–792. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang W, Kandimalla R, Huang H, Zhu L, Li
Y, Gao F, Goel A and Wang X: Molecular subtyping of colorectal
cancer: Recent progress, new challenges and emerging opportunities.
Semin Cancer Biol. 55:37–52. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zacharakis M, Xynos ID, Lazaris A, Smaro
T, Kosmas C, Dokou A, Felekouras E, Antoniou E, Polyzos A,
Sarantonis J, et al: Predictors of survival in stage IV metastatic
colorectal cancer. Anticancer Res. 30:653–660. 2010.PubMed/NCBI
|
|
11
|
Garcia MA, Nelson WJ and Chavez N:
Cell-cell junctions organize structural and signaling networks.
Cold Spring Harb Perspect Biol. 10:a0291812018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Anderson JM and Van Itallie CM: Physiology
and function of the tight junction. Cold Spring Harb Perspect Biol.
1:a0025842009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Martin TA: The role of tight junctions in
cancer metastasis. Semin Cell Dev Biol. 36:224–231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schuetz A, Radusheva V, Krug SM and
Heinemann U: Crystal structure of the tricellulin C-terminal
coiled-coil domain reveals a unique mode of dimerization. Ann NY
Acad Sci. 1405:147–159. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Oda Y, Otani T, Ikenouchi J and Furuse M:
Tricellulin regulates junctional tension of epithelial cells at
tricellular contacts through Cdc42. J Cell Sci. 127:4201–4212.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morampudi V, Graef FA, Stahl M, Dalwadi U,
Conlin VS, Huang T, Vallance BA, Yu HB and Jacobson K: Tricellular
tight junction protein tricellulin is targeted by the
enteropathogenic escherichia coli effector EspG1, leading to
epithelial barrier disruption. Infect Immun. 85:e00700–16.
2016.PubMed/NCBI
|
|
17
|
Takasawa A, Murata M, Takasawa K, Ono Y,
Osanai M, Tanaka S, Nojima M, Kono T, Hirata K, Kojima T and Sawada
N: Nuclear localization of tricellulin promotes the oncogenic
property of pancreatic cancer. Sci Rep. 6:335822016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Benson AB III, Venook AP, Cederquist L,
Chan E, Chen YJ, Cooper HS, Deming D, Engstrom PF, Enzinger PC,
Fichera A, et al: Colon cancer, version 1.2017, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
15:370–398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang F, Xu J, Li H, Tan M, Xiong X and Sun
Y: FBXW2 suppresses migration and invasion of lung cancer cells via
promoting β-catenin ubiquitylation and degradation. Nat Commun.
10:13822019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sadeghi MR, Jeddi F, Soozangar N, Somi MH,
Shirmohamadi M, Khaze V and Samadi N: Nrf2/P-glycoprotein axis is
associated with clinicopathological characteristics in colorectal
cancer. Biomed Pharmacother. 104:458–464. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hwang JY, Park JH, Kim MJ, Kim WJ, Ha KT,
Choi BT, Lee SY and Shin HK: Isolinderalactone regulates the
BCL-2/caspase-3/PARP pathway and suppresses tumor growth in a human
glioblastoma multiforme xenograft mouse model. Cancer Lett.
443:25–33. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qin M, Zhang J, Xu C, Peng P, Tan L, Liu S
and Huang J: Knockdown of NIK and IKKβ-binding protein (NIBP)
reduces colorectal cancer metastasis through down-regulation of the
canonical NF-κΒ signaling pathway and suppression of MAPK signaling
mediated through ERK and JNK. PLoS One. 12:e01705952017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ting L, Rad R, Gygi SP and Haas W: MS3
eliminates ratio distortion in isobaric multiplexed quantitative
proteomics. Nat Methods. 8:937–940. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tolonen AC and Haas W: Quantitative
proteomics using reductive dimethylation for stable isotope
labeling. J Vis Exp. 514162014.
|
|
26
|
Wang K, Shan Z, Duan L, Gong T, Liu F,
Zhang Y, Wang Z, Shen J and Lei L: iTRAQ-based quantitative
proteomic analysis of Yamanaka factors reprogrammed breast cancer
cells. Oncotarget. 8:34330–34339. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kanehisa M, Sato Y, Kawashima M, Furumichi
M and Tanabe M: KEGG as a reference resource for gene and protein
annotation. Nucleic Acids Res. 44:D457–D462. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao GX, Xu YY, Weng SQ, Zhang S, Chen Y,
Shen XZ, Dong L and Chen S: CAPS1 promotes colorectal cancer
metastasis via Snail mediated epithelial mesenchymal
transformation. Oncogene. 38:4574–4589. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu CY, Qin MB, Tan L, Liu SQ and Huang JA:
NIBP impacts on the expression of E-cadherin, CD44 and vimentin in
colon cancer via the NF-κB pathway. Mol Med Rep. 13:5379–5385.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zeisel MB, Dhawan P and Baumert TF: Tight
junction proteins in gastrointestinal and liver disease. Gut.
68:547–561. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
France MM and Turner JR: The mucosal
barrier at a glance. J Cell Sci. 130:307–314. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pastushenko I and Blanpain C: EMT
transition states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu CY, Liu SQ, Qin MB, Zhuge CF, Qin L,
Qin N, Lai MY and Huang JA: SphK1 modulates cell migration and
EMT-related marker expression by regulating the expression of p-FAK
in colorectal cancer cells. Int J Mol Med. 39:1277–1284. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ikenouchi J, Furuse M, Furuse K, Sasaki H
and Tsukita S and Tsukita S: Tricellulin constitutes a novel
barrier at tricellular contacts of epithelial cells. J Cell Biol.
171:939–945. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shimada H, Satohisa S, Kohno T, Takahashi
S, Hatakeyama T, Konno T, Tsujiwaki M, Saito T and Kojima T: The
roles of tricellular tight junction protein lipolysis-stimulated
lipoprotein receptor in malignancy of human endometrial cancer
cells. Oncotarget. 7:27735–27752. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schlachter K, Gyugos M, Halasz J, Lendvai
G, Baghy K, Garami M, Gyöngyösi B, Schaff Z and Kiss A: High
tricellulin expression is associated with better survival in human
hepatoblastoma. Histopathology. 65:631–641. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Masuda R, Semba S, Mizuuchi E, Yanagihara
K and Yokozaki H: Negative regulation of the tight junction protein
tricellulin by snail-induced epithelial-mesenchymal transition in
gastric carcinoma cells. Pathobiology. 77:106–113. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Somorácz A, Korompay A, Törzsök P, Patonai
A, Erdélyi-Belle B, Lotz G, Schaff Z and Kiss A: Tricellulin
expression and its prognostic significance in primary liver
carcinomas. Pathol Oncol Res. 20:755–764. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Naugler WE and Karin M: NF-kappaB and
cancer-identifying targets and mechanisms. Curr Opin Genet Dev.
18:19–26. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gilmore TD: Introduction to NF-kappaB:
Players, pathways, perspectives. Oncogene. 25:6680–6684. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Escarcega RO, Fuentes-Alexandro S,
Garcia-Carrasco M, Gatica A and Zamora A: The transcription factor
nuclear factor-kappa B and cancer. Clin Oncol (R Coll Radiol).
19:154–161. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kojima T, Fuchimoto J, Yamaguchi H, Ito T,
Takasawa A, Ninomiya T, Kikuchi S, Ogasawara N, Ohkuni T, Masaki T,
et al: c-Jun N-terminal kinase is largely involved in the
regulation of tricellular tight junctions via tricellulin in human
pancreatic duct epithelial cells. J Cell Physiol. 225:720–733.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xia Y, Shen S and Verma IM: NF-κB, an
active player in human cancers. Cancer Immunol Res. 2:823–830.
2014. View Article : Google Scholar : PubMed/NCBI
|
